In an attempt to design and synthesize a potent class of antimicrobials, 1,2-phenylenediamine derivatives were reacted with various aliphatic and heteroaliphatic dicarboxylic acids to generate a small library of 26 head-to-head bisbenzimidazole compounds (16 – 42) using the polyphosphoric acid method. These compounds were screened for their antibacterial activity and their antifungal activity. Compound 25 showed maximum potency against both Gram-positive and Gram-negative bacterial strains with minimum inhibitory concentration (MIC) values in the range of 7.81 – 31.25 μg/mL. In particular, it showed the maximum MIC values of 7.81 μg/mL against Gram-negative bacteria, which was four-fold more active than the standard drug ampicillin (MIC = 32.25 μg/mL). Compound 19 was found to be the most active against S. aureus with a MIC value of < 3.90 μg/mL, whereas the remaining compounds showed only low-to-moderate activity. Furthermore, all compounds exhibited low activity against all fungal strains in comparison to the standard drug fluconazole. I addition, pharmacophore hypotheses were generated to analyze structure–activity relationships between the molecular structures and antimicrobial activities on E. coli. This pharmacophore model can be useful in order to design new antimicrobial drugs. It can be suggested that the substitution of a phenyl ring at the 5/6 and 5′/6′ positions in symmetric bisbenzimidazole derivatives produces compounds with promising antimicrobial activity.
Similar content being viewed by others
References
European Centre for Disease Prevention and Control. https: //www.ecdc.europa.eu/en/news-events/33000-people-die-every-year-due-infections-antibiotic-resistant-bacteria
S. Kurakata, K. Fujiwara, and T. Fujita, 2000-JP4858 2001005402, 20000719 (2001).
D. Carcanague, Y. K. Shue, M. A. Wuonola, et al., J. Med. Chem., 45(19), 4300 – 4309 (2002).
O. Algul and N. Duran, Asian J. Chem., 19(4), 3145 – 3151 (2007).
N. M. Aghatabay, M. Somer, M. Senel, et al., Eur. J. Med. Chem., 42(8) 1069 – 1075 (2007).
V. A. Mamedov, RSC Adv., 6(48) 42132–42172 (2016).
A. K. Tewari and A. Mishra, Indian J. Chem., Sect. B: Org. Med. Chem., 45, 489 – 493 (2006).
S. Demirayak, A. C. Karaburun, I. Kayagil, et al., Phosphorous, Sulfur, Silicon Relat. Elem., 180(8), 1841 – 1848 (2005).
J. M. Gardiner and C. R. Loyns, Tetrahedron, 51(42), 11515 – 11530 (1995).
Y. Bansal, O. Silakari, Bioorg. Med. Chem., 20(21), 6208 – 6236 (2012).
N. Ranjan, S. Story, G. Fulcrand, et al., J. Med. Chem., 60(12) 4904 – 4922 (2017).
R. Patil, A. Kulshrestha, A. Tikoo, et al., Molecules, 22(9), 1559 (2017).
V. S. Koval, A. F. Arutyunyan, V. L. Salyanov, et al., Bioorg. Med. Chem., 26(9), 2302 – 2309 (2018).
A. Mayence, A. Pietka, M. S. Collins, et al., Bioorg. Med. Chem. Lett., 18(8), 2658 – 2661(2008).
M. P. Barrett, C. G. Gemmell, and C. J. Suckling, Pharmacol. Ther., 139(1), 12 – 23 (2013).
L. Hu, M. L. Kully, D. W. Boykin, and N. Abood, Bioorg. Med. Chem. Lett., 19(13), 3374 – 3377 (2009).
L. Hu, M. L. Kully, D. W. Boykin, and N. Abood, Bioorg. Med. Chem. Lett., 19(5), 1292 – 1295 (2009).
L. Hu, M. L. Kully, D. W. Boykin, and N. Abood, Bioorg. Med. Chem. Lett., 19(16), 4626 – 4629 (2009).
J. Mann, P.W. Taylor, C. R. Dorgan, et al., Med. Chem. Comm., 6(8), 1420 – 1426 (2015).
Y. He, J. Yang, B. Wu, et al., Bioorg. Med. Chem. Lett., 14(5), 1217 – 1220 (2008).
J. B. Moreira, J. Mann, S. Neidle, et al., Int. J. Antimicrob. Agents, 42(4), 361 – 366 (2013).
G. Bashiardes, Benzothiazole-2-thiol, in: e-EROS Encyclopedia of Reagents for Organic Synthesis, 1 – 7 (2005).
O. Algul, A. Kaessler, Y. Apcin, et al., Molecules, 13(13), 736 – 748 (2008).
H. A. Elagab and H. G. Alt, Inorg. Chim. Acta, 437, 26 – 35 (2015).
U. Yilmaz and H. Kucukbay, Phosphorus, Sulfur, Silicon Relat. Elem., 191(1), 140 – 143 (2016).
M. R. Grimmett, Sci. Synth., 12, 529 – 612 (2002).
S. Mao, K. Shen, X. Shi, et al., Inorg. Chim. Acta, 471, 82 – 90 (2018).
H. Wu, F. Wang, F. Shi, et al., Transit. Met. Chem., 40(5), 555 – 564 (2015).
P. Kopel, D. Wawrzak, V. Langer, et al., Molecules, 20(6), 10360 – 10376 (2015).
K. Dimroth, N. Greif, and A. Klapproth, Justus Liebigs Annalen der Chemie, 2, 373 – 86 (1975).
P. A. Levin, Zh. Obshch. Khim., 26, 2543 – 4 (1956).
G. Cakir, U. Ucucu, and U. Abbasoglu, Gazi Universitesi Eczacilik Fakultesi Dergisi, 5(1), 105 – 10 (1988).
R. T. Stibrany, ACS Symposium Series, 857, 210 – 221 (2003).
Y. Sun, G. Duan, J. Liu, and J. Wang, Youji Huaxue, 26(7), 942 – 945 (2006).
S. Akihama and K. Takahashi, Yakugaku Zasshi, 90(10), 1305 – 9 (1970).
C. Mukhopadhyay, S. Ghosh, and R. J. Butcher, ARKIVOC, 9, 75 – 96 (2010).
M. Berrada, Z. Anbaoui, N. Lajrhed, et al., Chem. Mater., 9(9), 1989 – 1993 (1997).
D. Castillo, R. Cervantes, C. Frontana, et al., J. Phys. Org., 27(8), 701 – 706 (2014).
G. Bhave, B. A. Chauder,W. Liu, et al., Mol. Pharmacol., 79(1), 42 – 50 (2011).
N. S. El-Gohary and M. I. Shaaban, Eur. J. Med. Chem., 137, 439 – 449 (2017).
D. Gilbert, European Patent Application, EP 121326 (1984).
G. L.Woods and J. A.Washington, Manual of Clinical Microbiology, 6th ed., American Society for Microbiology, Washington, DC (1995), pp. 1327–1341.
J. H. Jorgensen and M. J. Ferraro, Clin. Infect. Dis., 26(4) 973–80 (1998).
Schrödinger Release 2018 – 2: LigPrep, Schrödinger LLC, New York (2019).
S. L. Dixon, A. M. Smondyrev, and S. N. Rao, Chem. Biol. Drug Des., 67(5), 370 – 372 (2006).
D. Song and S. Ma, ChemMedChem, 11(7), 646 – 659 (2016).
H. Nimesh, S. Sur, D. Sinha, et al., J. Med. Chem., 57(12), 5238 – 5257 (2014).
N. Mani, C. H. Gross, J. D. Parsons, et al., Antimicrob. Agents Chemother., 50(4), 1228 – 1237 (2006).
A. G. Dale, J. Hinds, J. Mann, et al., Biochemistry, 51(29), 5860 – 5871 (2012).
N. T. Chandrika, S. K. Shrestha, H. X. Ngo, and S. Garneau-Tsodikova, Bioorg. Med. Chem., 24(16), 3680 – 3686 (2016).
Acknowledgements
This study was supported by 2015-AP3-1228 BAP Projects of Mersin University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ersan, R.H., Bolelli, K., Gonca, S. et al. Bisbenzimidazole Derivatives as Potential Antimicrobial Agents: Design, Synthesis, Biological Evaluation and Pharmacophore Analysis. Pharm Chem J 55, 149–158 (2021). https://doi.org/10.1007/s11094-021-02389-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-021-02389-x